OncoLink logoSeveral foundations are making emergency financial aid available to cancer patients who may be affected by coronavirus and covid-19. They can help with things like drug & grocery delivery, transportation to chemotherapy (so you can avoid public transportation), child-care, and other expenses that help you to stay safe at home.

OncoLink is maintaining a web page that keeps track of open funds and eligibility requirements. Since fund availability changes rapidly, it is a good idea to check the OncoLink page frequently.

Best wishes to everyone. Stay safe!

Myeloma Crowd LogoMyeloma Crowd and HealthTree have opened a COVID-19 Myeloma Patient Study. It is a series of questions that have been created by the Myeloma Crowd Multiple Myeloma Research Review Board. These myeloma experts and the Myeloma Crowd want to know how COVID-19 is affecting myeloma patients.

The anonymous answers will be aggregated and analyzed by myeloma researchers to identify recommendations that will help all myeloma patients know how best be protected and effectively treated for both COVID-19 and their myeloma. Their goal is to include 1,000 myeloma and precursor condition (MGUS and smoldering myeloma) patients and to provide reporting results quickly.

Each study participant will receive a free rapid COVID-19 antibody test. This is a finger prick blood test that identifies if you have developed coronavirus antibodies.This rapid test was used in a 3200 patient Stanford University study and has been verified in a CLIA (Clinical Laboratory Improvement Amendments) approved lab.

Please note that you must be registered with HealthTree to participate in the study. For more information, go to

PMMNG Members

The Philadelphia Multiple Myeloma Networking Group’s (PMMNG) mission is to be an ongoing resource for myeloma patients, their families and friends.

PMMNG Vision

Provide hope to the Myeloma community through education, companionship, compassion, and advocacy while working toward a cure.

PMMNG Mission

  • Enrich the lives of patients and their families through programs and resources for living with and conquering myeloma
  • Foster connections and dialogue among members at all stages of the myeloma journey
  • Open pathways for patients seeking treatment by building and sustaining relationships with area medical centers, national myeloma organizations and pharmaceutical companies.
  • Provide support for organizations advancing research and financial assistance for myeloma treatment
  • Advocate for research and legislation regarding effective treatment and quality of life

Who We Are

The PMMNG was formed in 1995, and is a diverse group of myeloma patients, their caregivers and support persons.

From an original meeting around a kitchen table, the founding members led the organization to find more appropriate meeting space, an experienced group facilitator and many more members.

Phil Falkowitz and his wife, Barbara, along with Marilyn Alexander and her twin sister, Sharon, mobilized efforts to include patient education, political advocacy and fundraising for Myeloma research. Meeting notices spread throughout the Philadelphia region and relationships with local cancer organizations were established.

In 1999, the growing group found its current home at the Ralston House. The membership list grew to upwards of 300 members. At present, the PMMNG is affiliated with the International Myeloma Foundation (IMF). The PMMNG is led by a Steering Committee and is known in the region as a safe haven for families dealing with myeloma.

Certainly we wish there were no need for a group such as ours, but we take comfort from the fact that we have been able to reach and assist so many more people than the small group who met more than 20 years ago.

Group Facilitators

Maddie Hunter: [email protected] or 732-549-7981
Marilyn Alexander: [email protected] or 215-694-4146 

Direct Contact

PMMNG: [email protected]

Medical Advisors

Dr. Edward Stadtmauer and Dr. Dan Vogl,
Abramson Cancer Center, University of Pennsylvania